Completed PHASE4 INTERVENTIONAL 3-arm NCT00738296

Vytorin on Carotid Intima-media Thickness and Overall Rigidity (VYCTOR)

Sponsor: Hospital Universitario 12 de Octubre

Interventions ezetimibe (+) simvastatin pravastatin simvastatin

Updated 7 times since 2017 Last updated: Jun 23, 2015 Started: Apr 30, 2005 Primary completion: Dec 31, 2005 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00738296, this PHASE4 trial focuses on Cardiovascular Diseases and remains completed. Sponsored by Hospital Universitario 12 de Octubre, it has been updated 7 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jun 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Jun 2022 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitario 12 de Octubre
Merck Sharp & Dohme LLC

Data source: Hospital Regional 1o de Octubre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.